Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Louisiana Bills to Watch

Three in-progress bills impact medical reimbursement and fee schedules, prescription drug authorizations, and medical necessity evaluations.

Read More →

May 4, 2026

Claim Costs Claim Data

WCRI Publishes CompScope Benchmarks

Claim costs increased 6% per year from 2022-2025 in the median study state, with state-level variations.

Read More →

May 4, 2026

Marijuana

Marijuana Rescheduled by DOJ and DEA

FDA-approved products and state-regulated medical products are now Schedule III, effective immediately.

Read More →

April 27, 2026

Advocacy Opportunity Training Opportunity

Insights from the 2026 IAIABC Forum

Discussions centered around evolving approaches to carrier compliance and oversight, reflecting an increasing shift toward data-driven system alignment.

Read More →

April 27, 2026

Advocacy Opportunity Training Opportunity

Insights From the Delaware/Pennsylvania WCRB Forum

Among many educational sessions, Sandy Shtab, Healthesystems VP of Industry and State Affairs, joined a panel on Medical Experience.

Read More →

April 27, 2026

Mental Health Psychedelics

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.

Read More →

April 27, 2026

Claim Costs Pharmacy Data

Minnesota Publishes Drug Price Transparency Report

Prescription drug list prices increased 23% in the last year, far outpacing inflation.

Read More →

April 27, 2026

Worker Classification

New York Could Exclude Unpaid Interns from Workers’ Comp

Such interns would not be considered employees, meaning they would not be entitled to various employee benefits.

Read More →

April 27, 2026

Marijuana Worker Safety

Oklahoma Employers Can Terminate Employees for Any Marijuana Use

Positive drug tests, even for medical use, can result in termination. The bill also updates rules around safety sensitive positions.

Read More →

April 27, 2026

« Previous 1 … 4 5 6 7 8 … 56 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

INFOGRAPHIC: Current State of Complex Claims in Workers’ Comp

Statistics from recent studies across the industry shed light on complex claims in workers' compensation.

State of the Nation

Sandy Shtab, VP of Industry and State Affairs, shares policy perspectives.

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.

NCCI Publishes 2025 Regulatory and Legislative Trends Report

NCCI tracked 950 bills impacting workers’ comp, highlighting key trends across the country, such as PTSD and cancer presumptions, worker classification, and psychedelics.